William F. Mieler

Chair(s): William F. Mieler (United States); Francesco Bandello (Italy);

It is impossible to manage AMD without OCTA - YES
Eric Souied (France)
It is impossible to manage AMD without OCTA - NO
William F. Mieler (United States)
It is impossible to manage diabetic retinopathy without OCTA - YES
Francesco Bandello (Italy)
It is impossible to manage diabetic retinopathy without OCTA - NO
Sobha Sivaprasad (United Kingdom)
It is impossible to manage retinal vein occlusions with OCTA - YES
Caroline Baumal (United States)
It is impossible to manage retinal vein occlusions with OCTA - NO
Srinivas Sadda (United States)

Topic: Medical Retina

Chair(s): Allen Ho (United States); William F. Mieler (United States);

Introduction
Allen Ho (United States)
Advances toward Photoreceptor Transplantation
Raymond Iezzi (United States)
Residual Fluid and Anatomic Correlates in the Treatment of Neovascular Age-related Macular Degeneration
Srinivas Sadda (United States)
Towards More Durable Anti VEGF Therapy for Neovascular AMD: Port Delivery
Dante J. Pieramici (United States)
Next Generation Anti VEGF therapies
Peter Kaiser (United States)
Updates on Ocular Drug Delivery Systems
Jennifer Kang-Mieler (United States)
Gene Therapy for Inherited and Acquired Retinal Disorders: Now and Future
Szilard Kiss (United States)
Top Take Home Lessons from the DRCR Network Trials
Jennifer Sun (United States)
Surgical Pearls for Difficult Diabetic Traction Detachment
Maria Berrocal (Puerto Rico)
Panel Discussion
William F. Mieler (United States)
Conclusion
Allen Ho (United States)

Topic: Medical Retina

Chair(s): Susan MacDonald (United States); Richard Packard (United Kingdom); Jan Talma (South Africa);

Early recognition of PCR
Ahmed Ghoneim (Egypt)
Limbal anterior vitrectom- why & how
Susan MacDonald (United States)
Pars plana anterior vitrectom-– why & how
Khaled Abdelrahman (Egypt)
Managing the descending nucleus
Richard Packard (United Kingdom)
Anterior vitrectomy pitfalls for cataract surgeons
William F. Mieler (United States)
Converting to ECCE
David Chang (United States)
IOL Implantation following PCR
Boris Malyugin (Russian Federation)
Discussing complications with patients
Jan Talma (South Africa)

Topic: Cataract and Lens Surgery

Chair(s): S. Natarajan (India); Abdulaziz Badla (Syrian Arab Republic);

Pellet Ocular Trauma – The Worlds’ largest Series
S. Natarajan (India)
Perforating Posterior Trauma in a Child/ Combined Hemorrhagic Choroidal & Retinal Detachment
Faisal Fayyad (Jordan)
Posterior Segment in IOFB
Abdulaziz Badla (Syrian Arab Republic)
Controversies in the Management of Posterior Segment Open-Globe Injuries
William F. Mieler (United States)
Use of perfluorocarbon as temporary buffer in cases of complex vitrectomies
Hugo Ocampo (Colombia)
Panoramic Keratoprosthesis in trauma
Jose Dalma-Weiszhausz (Mexico)

Topic: Surgical Retina

Chair(s): Dante J. Pieramici (United States); Samantha Fraser-Bell (Australia);

AMD: RPE Stem cell transplantation
Raymond Iezzi (United States)
Myopia: What does the future hold?
Jost Jonas (Germany)
Uveitis: Does the microbiome matter?
Nida Sen (United States)
Retinal toxicities: Drugs that poison the retina
William F. Mieler (United States)
Artificial intelligence: Has it arrived in retina?
Eleonora Lad (United States)

Topic: Medical Retina

Chair(s): Taiji Sakamoto (Japan);

Topic: Ophthalmic Pharmacology